NEW YORK (TheStreet) -- Merck (MRK - Get Report) stock is falling by 1.02% to $56.41 on Tuesday morning although the pharmaceutical company posted strong fiscal 2015 second quarter earnings results that beat …
The Street · 1 day ago
Merck & Co., Inc (Symbol: MRK) has been named a Top Socially Responsible Dividend Stock by Dividend Channel, signifying a stock with above-average ''DividendRank'' statistics including a strong 3.1% yield, as well as being recognized by prominent asset ...
NASDAQ · 16 hours ago
Similar to MRK, skepticism has been running high in PFE's options pits, per the stock's 10-day ISE/CBOE/PHLX put/call volume ratio of 1.23 -- in the 92nd percentile of its annual range. Plus, 63% of analysts still …
Schaeffer's Investment Research · 19 hours ago
More from Bing News
Merck & Co. (NYSE:MRK) has been given an “AA” credit rating by Morningstar. The research firm’s “AA” rating indicates that the company is a very-low default risk. They also gave their stock a four star rating. Several other research analysts have ... · 17 hours ago
Carter’s, Inc. (CRI)’s monthly performance stand at – 0.87% with a profit margin of 8.30% and has an analyst rating of 1.9 (Click To Expand Current Stock Data:) Merck & Co. Inc. (MRK) of the Healthcare sector … · 16 hours ago
Novo Nordisk A/S (NVO): NVO stock is up 0.8% today. Novartis Ag (NVS): NVS stock is up 0.7% today. Merck & Company (MRK): MRK stock is up 0.7% today. Some of the biggest losers among healthcare stocks include: Dr. Reddy’s Laboratories Ltd …
Investor Place · 13 hours ago
Healthcare Stocks
New Jersey-based Merck (MRK - Analyst Report), is a global research-driven pharmaceutical products company. Well known products in Merck’s portfolio include Remicade, Nasonex, Simponi, Vytorin and Zetia, Januvia and Janumet, Isentress, PegIntron ...
ZACKS · 1 day ago
Merck (NYSE:MRK) has potential upside of 11.8% based on a current price of $58.69 and analysts' consensus price target of $65.62. The stock should hit resistance at its 200-day moving average (MA) of $58.73, as well as support at its 50-day MA of $58.61.
Financial News Network Online · ByMallory Stone · 12 hours ago
The stock’s 52-week range is $40.12 to $50.05. Trading volume was slightly above the daily average of around 32 million. The company released Windows 10 into the wild today, and reviews have been mostly positive.
24/7 Wall ST · 11 hours ago
MRK reported second-quarter earnings of $0.86 per share ... confidence in shareholders as shares fell sharply immediately after the earnings report. The stock did recover in late trading though to finish 0.91% higher at $57.51. Looking ahead, Remicade ...
Seeking Alpha · 18 hours ago
Merck Earnings

Merck & Co.

Merck & Co., Inc., d.b.a. Merck Sharp & Dohme outside the United States and Canada, is an American pharmaceutical company and one of the l…
Merck & Co., Inc., d.b.a. Merck Sharp & Dohme outside the United States and Canada, is an American pharmaceutical company and one of the largest pharmaceutical companies in the world. Merck headquarters is located in Kenilworth, New Jersey. The company was established in 1891 as the United States subsidiary of the German company Merck. Merck & Co. was confiscated by the US government during World War I and subsequently established as an independent American company. It is the world's seventh largest pharmaceutical company by market capitalization and revenue.
Data from: Wikipedia · Freebase